Business

Arno Therapeutics Announces Cancellation of Special Meeting of Stockholders

Arno Therapeutics Announces Cancellation of Special Meeting of Stockholders.

articleArno Therapeutics IncDecember 21, 20165/company/arno-therapeutics/news/arno-therapeutics-announces-cancellation-of-special-meeting-of-stockholders
Arno Therapeutics Announces Cancellation of Special Meeting of Stockholders

About this update from Arno Therapeutics Inc

[{"type":"text","content":"\n \n Arno Therapeutics, Inc. (OTCQB: ARNI), a clinical stage \n biopharmaceutical company focused on the development of therapeutics for \n cancer and other life threatening diseases, today announced that it has \n cancelled the special meeting of stockholders scheduled for December 22, \n 2016. The Company will consider at a later date whether to seek \n stockholder approval of the proposed amendments to its certificate of \n incorporation to implement a reverse split and reduce its authorized \n common stock.\n \n \n About Arno Therapeutics\n \n \n Arno Therapeutics is a clinical stage biopharmaceutical company \n developing innovative products for the treatment of cancer and other \n life threatening diseases. Arno has exclusive worldwide rights to \n develop and market three innovative anti-cancer product candidates. \n These compounds are in clinical or preclinical development. For more \n information about the company, please visit www.arnothera.com.\n \n \n Forward-Looking Statements\n \n \n This press release contains forward-looking statements that involve \n substantial risks and uncertainties. These statements are often, but not \n always, made through the use of words or phrases such as \"anticipates,\" \n \"expects,\" \"plans,\" \"believes,\" \"intends,\" and similar words or phrases. \n These forward-looking statements include, without limitation, statements \n regarding the timing, progress and anticipated results of the clinical \n development of onapristone, statements regarding Arno’s available cash \n resources, as well as Arno's strategy, future operations, outlook, \n milestones, future financial position, future financial results, plans \n and objectives. Arno may not actually achieve these plans, intentions or \n expectations and Arno cautions investors not to place undue reliance on \n our forward-looking statements. Actual results or events could differ \n materially from the plans, intentions and expectations disclosed in the \n forward-looking statements we make. Various important factors could \n cause actual results or events to differ materially from the \n forward-looking statements that we make. Such factors include, among \n others, risks that we will not obtain the capital necessary to fund our \n operations in a timely manner, if ever, or on acceptable terms, that if \n we are ...

More updates from Arno Therapeutics Inc